Tokyo, Aug. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062502) titled 'A systematic review of the functionality of "ampelopsin" for a function to reduce abdominal fat (visceral and subcutaneous fat), body weight, BMI, and blood lipids in healthy adults' on Aug. 7.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate whether the intake of ampelopsin effect function to reduce abdominal fat (visceral and subcutaneous fat), body weight, BMI, and blood lipids in healthy adults, including the latest RCTs. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - P-Participant: Participant The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women)

I-intervention: Intervention (food) characteristics Continuous intake of ampelopsin, Unlimited dosage forms, period and follow-up period.

C-Comparison: Comparison Placebo (The placebo's formulation is not specified)

O-Outcome: Outcome The primary outcome: abdominal fat (total abdominal fat area, visceral fat area, and subcutaneous fat area), body weight, body mass index (BMI), and blood lipids (total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides) The secondary outcome: Do not set

S-Study design: Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials or open trial Key exclusion criteria - The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 05 Day Anticipated trial start date - 2026 Year 08 Month 07 Day Last follow-up date - 2026 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071553

Disclaimer: Curated by HT Syndication.